Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PARP1 | P09874 | 4/20 | 0.38 |
| ▸ | PARP2 | Q9UGN5 | 2/20 | 0.38 |
| ▸ | PARP3 | Q9Y6F1 | 1/20 | 0.38 |
| ▸ | P2RX7 | Q99572 | 4/20 | 0.34 |
| ▸ | NR3C1 | P04150 | 1/20 | 0.31 |
| ▸ | NR3C2 | P08235 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17946565 | 0.86 | P2RX7 (0.33) | P2RX7 | |
| SCHEMBL17947190 | 0.86 | P2RX7 (0.34) | P2RX7 | |
| SCHEMBL17946377 | 0.84 | ROCK1 (0.38) | PARP1PARP2PARP3P2RX7 | |
| SCHEMBL13954 | 0.83 | MC4R (0.39) | PARP1P2RX7 | |
| SCHEMBL17947197 | 0.82 | ALDH1A1 (0.36) | PARP1 | |
| SCHEMBL14019 | 0.81 | MPO (0.39) | P2RX7 | |
| SCHEMBL17946976 | 0.81 | CYP1A2 (0.47) | — | |
| SCHEMBL17946396 | 0.81 | MLLT1 (0.37) | — | |
| SCHEMBL17946394 | 0.80 | P2RX7 (0.33) | P2RX7 | |
| SCHEMBL20019944 | 0.80 | PARP1 (0.37) | PARP1PARP2PARP3P2RX7NR3C1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10815238-B2 | Antimicrobial compounds and methods of making and using the same | BioVersys AG (CH) | 2020-10-27 | — | — | US | disclosed |
| US-20190284190-A1 | ANTIMICROBIAL COMPOUNDS AND METHODS OF MAKING AND USING THE SAME | BioVersys AG (CH) | 2019-09-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190284190-A1 | ANTIMICROBIAL COMPOUNDS AND METHODS OF MAKING AND USING THE SAME | MPO, LPO, CAT | PARP1 1384/4885PARP2 1743/4885PARP3 1982/4885 |
| US-10815238-B2 | Antimicrobial compounds and methods of making and using the same | MPO, LPO, CAT | PARP1 1384/4885PARP2 1743/4885PARP3 1982/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.